Table: Delta-Fly Pharma - Q1 parent results

Delta-Fly Pharma

08/08/2025 07:39

Aug 8 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Jun 30, 2025        Jun 30, 2024       Mar 31, 2026  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating     loss 358 mln        loss 497 mln        loss 1.50    
  Recurring     loss 366 mln        loss 499 mln        loss 1.51    
  Net           loss 367 mln        loss 500 mln        loss 1.51    
  EPS          loss 35.43 yen      loss 60.78 yen    loss 155.45 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T